<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39452485</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2079-9721</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>Diseases (Basel, Switzerland)</Title><ISOAbbreviation>Diseases</ISOAbbreviation></Journal><ArticleTitle>Unraveling Pneumomediastinum in COVID-19 Patients: Insights from a High-Volume-Center Case-Control Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">242</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/diseases12100242</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pneumomediastinum (PNM) is a severe complication in COVID-19 patients, potentially exacerbating morbidity and requiring heightened clinical attention. This study aims to identify risk factors, clinical characteristics, and outcomes associated with PNM in COVID-19 patients hospitalized for respiratory failure in our institution.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Among 4513 patients admitted in our institution and testing positive for COVID-19 infection during the peak of the COVID-19 pandemic in Italy (1 March 2020 to 31 July 2020), we conducted a single-center, retrospective case-control study focusing our analysis on those with severe disease (respiratory failure). The cohort included a total of 65 patients (32 with PNM and 33 without PNM in the same period). Data were retrospectively collected from hospital records, including demographics, comorbidities, smoking history, clinical and laboratory findings, and imaging results. Statistical analyses were performed using Fisher's exact test and Student's <i>t</i>-test, with significance set at α = 0.05.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients with PNM were significantly younger (54.9 ± 18.5 vs. 65.4 ± 14.3 years, <i>p</i> = 0.0214) and exhibited higher inflammatory markers, particularly white blood cells count (WBC) at admission (11.4 ± 5.4 vs. 6.5 ± 4.1, <i>p</i> &lt; 0.0001). Although smoking status, body mass index (BMI), and major comorbidities did not differ significantly between groups, COPD was more prevalent in the PNM group (46.9% vs. 15.1%, <i>p</i> = 0.0148). Radiologically, ground-glass opacities (GGOs) and consolidations were more frequent in PNM patients (93.7% vs. 51.5%, <i>p</i> = 0.0002; 78.1% vs. 42.2%, <i>p</i> = 0.0051, respectively). PNM was associated with longer hospital stays (28.5 ± 14.9 vs. 12.0 ± 7.2 days, <i>p</i> &lt; 0.0001) and a higher need for invasive mechanical ventilation (53.1% vs. 30.3%, <i>p</i> = 0.0619). However, mortality rates did not differ significantly between groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PNM in patients with severe COVID-19 infection is associated with younger age, elevated inflammatory markers, and extensive lung involvement, contributing to increased morbidity and prolonged hospitalization. Early detection and tailored management strategies, including optimized respiratory support and aggressive anti-inflammatory therapies, are crucial in mitigating the adverse outcomes associated with PNM. Further research is needed to validate these findings and improve clinical protocols for managing this complication.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kuzmych</LastName><ForeName>Khrystyna</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-6399-9171</Identifier><AffiliationInfo><Affiliation>Thoracic Surgery Unit, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Covino</LastName><ForeName>Marcello</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6709-2531</Identifier><AffiliationInfo><Affiliation>Emergency Department, Fondazione Policlinico Universitario Gemelli IRCCS, 00168 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paratore</LastName><ForeName>Mattia</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7546-8041</Identifier><AffiliationInfo><Affiliation>Diagnostic and Interventional Ultrasound Unit, CEMAD Digestive Disease Center, Internal Medicine and Gastroenterology, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campanella</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Thoracic Surgery Unit, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abenavoli</LastName><ForeName>Ludovico</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-5922-1524</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences, University "Magna Græcia", 88100 Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calabrese</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">0009-0003-5070-1315</Identifier><AffiliationInfo><Affiliation>Thoracic Surgery Unit, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Napolitano</LastName><ForeName>Antonio Giulio</ForeName><Initials>AG</Initials><Identifier Source="ORCID">0000-0002-4058-5539</Identifier><AffiliationInfo><Affiliation>Thoracic Surgery Unit, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sassorossi</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-4654-1577</Identifier><AffiliationInfo><Affiliation>Thoracic Surgery Unit, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Margaritora</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Thoracic Surgery Unit, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Thoracic Surgery Unit, Fondazione Policlinico Universitario Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lococo</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-9383-5554</Identifier><AffiliationInfo><Affiliation>Thoracic Surgery Unit, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Thoracic Surgery Unit, Fondazione Policlinico Universitario Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Diseases</MedlineTA><NlmUniqueID>101636232</NlmUniqueID><ISSNLinking>2079-9721</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">pneumomediastinum</Keyword><Keyword MajorTopicYN="N">respiratory failure</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39452485</ArticleId><ArticleId IdType="pmc">PMC11506847</ArticleId><ArticleId IdType="doi">10.3390/diseases12100242</ArticleId><ArticleId IdType="pii">diseases12100242</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tetaj N., Garotto G., Albarello F., Mastrobattista A., Maritti M., Stazi G.V., Marini M.C., Caravella I., Macchione M., De Angelis G., et al. Incidence of Pneumothorax and Pneumomediastinum in 497 COVID-19 Patients with Moderate–Severe ARDS over a Year of the Pandemic: An Observational Study in an Italian Third Level COVID-19 Hospital. J. Clin. Med. 2021;10:5608. doi: 10.3390/jcm10235608.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10235608</ArticleId><ArticleId IdType="pmc">PMC8658701</ArticleId><ArticleId IdType="pubmed">34884310</ArticleId></ArticleIdList></Reference><Reference><Citation>Belletti A., Palumbo D., Zangrillo A., Fominskiy E.V., Franchini S., Dell’Acqua A., Marinosci A., Monti G., Vitali G., Colombo S., et al. Predictors of Pneumothorax/Pneumomediastinum in Mechanically Ventilated COVID-19 Patients. J. Cardiothorac. Vasc. Anesth. 2021;35:3642–3651. doi: 10.1053/j.jvca.2021.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2021.02.008</ArticleId><ArticleId IdType="pmc">PMC8054543</ArticleId><ArticleId IdType="pubmed">33678544</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.J., Kim J., Lee K.H., Lee J.A., Kim C.H., Lee S.H., Park B.J., Kim J.H., Ahn J.Y., Jeong S.J., et al. Risk factors of pneumothorax and pneumomediastinum in COVID-19: A matched case–control study. BMC Infect. Dis. 2023;23:1–9. doi: 10.1186/s12879-023-08104-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08104-3</ArticleId><ArticleId IdType="pmc">PMC9990560</ArticleId><ArticleId IdType="pubmed">36882735</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong W.H., Saha B.K., Hu K., Chopra A. The incidence, clinical characteristics, and outcomes of pneumothorax in hospitalized COVID-19 patients: A systematic review. Hear. Lung. 2021;50:599–608. doi: 10.1016/j.hrtlng.2021.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrtlng.2021.04.005</ArticleId><ArticleId IdType="pmc">PMC8088235</ArticleId><ArticleId IdType="pubmed">34087677</ArticleId></ArticleIdList></Reference><Reference><Citation>Piroth L., Cottenet J., Mariet A.-S., Bonniaud P., Blot M., Tubert-Bitter P., Quantin C. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: A nationwide, population-based retrospective cohort study. Lancet Respir. Med. 2021;9:251–259. doi: 10.1016/S2213-2600(20)30527-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30527-0</ArticleId><ArticleId IdType="pmc">PMC7832247</ArticleId><ArticleId IdType="pubmed">33341155</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafiee M.J., Fard F.B., Samimi K., Rasti H., Pressacco J. Spontaneous pneumothorax and pneumomediastinum as a rare complication of COVID-19 pneumonia: Report of 6 cases. Radiol. Case Rep. 2021;16:687–692. doi: 10.1016/j.radcr.2021.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.radcr.2021.01.011</ArticleId><ArticleId IdType="pmc">PMC7790462</ArticleId><ArticleId IdType="pubmed">33437348</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy R.K., Charles W.N., Sklavounos A., Dutt A., Seed P.T., Khajuria A. The effect of smoking on COVID-19 severity: A systematic review and meta-analysis. J. Med. Virol. 2020;93:1045–1056. doi: 10.1002/jmv.26389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26389</ArticleId><ArticleId IdType="pmc">PMC7436545</ArticleId><ArticleId IdType="pubmed">32749705</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanduzzi A., Ciasullo E., Capitelli L., Zamparelli S.S., Bocchino M. Alpha-1-Antitrypsin Deficiency and Bronchiectasis: A Concomitance or a Real Association? Int. J. Environ. Res. Public Health. 2020;17:2294. doi: 10.3390/ijerph17072294.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17072294</ArticleId><ArticleId IdType="pmc">PMC7178111</ArticleId><ArticleId IdType="pubmed">32235324</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott H.C., Sussman J.B., Wiersinga W.J. Postcritical illness vulnerability. Curr. Opin. Crit. Care. 2020;26:500–507. doi: 10.1097/MCC.0000000000000761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCC.0000000000000761</ArticleId><ArticleId IdType="pubmed">32773618</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J.M., Bai P., He W., Wu F., Liu X.F., Han D.M., Liu S., Yang J.K. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front. Public Health. 2020;8:152. doi: 10.3389/fpubh.2020.00152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00152</ArticleId><ArticleId IdType="pmc">PMC7201103</ArticleId><ArticleId IdType="pubmed">32411652</ArticleId></ArticleIdList></Reference><Reference><Citation>Juárez-Lloclla J.P., León-Jiménez F., Urquiaga-Calderón J., Temoche-Nizama H., Bryce-Alberti M., Portmann-Baracco A., Bryce-Moncloa A. Spontaneous Pneumopericardium and Pneumomediastinum in Twelve COVID-19 Patients. Arch. De Bronconeumol. 2020;57:86–88. doi: 10.1016/j.arbres.2020.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arbres.2020.09.013</ArticleId><ArticleId IdType="pmc">PMC7546662</ArticleId><ArticleId IdType="pubmed">34629677</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng C.F.S., Seposo X.T., Moi M.L., Tajudin M.A.B.A., Madaniyazi L., Sahani M. Characteristics of COVID-19 epidemic and control measures to curb transmission in Malaysia. Int. J. Infect. Dis. 2020;101:409–411. doi: 10.1016/j.ijid.2020.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.027</ArticleId><ArticleId IdType="pmc">PMC7567666</ArticleId><ArticleId IdType="pubmed">33075527</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B., Kojima S., Kawamoto A., Fukushima M. COVID-19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations. J. Med. Virol. 2020;93:2694–2704. doi: 10.1002/jmv.26754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26754</ArticleId><ArticleId IdType="pubmed">33368358</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle D.M., Kim-Schulze S., Huang H.-H., Beckmann N.D., Nirenberg S., Wang B., Lavin Y., Swartz T.H., Madduri D., Stock A., et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 2020;26:1636–1643. doi: 10.1038/s41591-020-1051-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Quartier P. Juvenile Idiopathic Arthritis-Associated Chronic Uveitis: Recent Therapeutic Approaches. J. Clin. Med. 2021;10:2934. doi: 10.3390/jcm10132934.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10132934</ArticleId><ArticleId IdType="pmc">PMC8269439</ArticleId><ArticleId IdType="pubmed">34208973</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldhoen S., Heidenreich J.F., Metz C., Petritsch B., Benkert T., Hebestreit H.U., Bley T.A., Köstler H., Weng A.M. Three-dimensional Ultrashort Echotime Magnetic Resonance Imaging for Combined Morphologic and Ventilation Imaging in Pediatric Patients With Pulmonary Disease. J. Thorac. Imaging. 2020;36:43–51. doi: 10.1097/RTI.0000000000000537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RTI.0000000000000537</ArticleId><ArticleId IdType="pubmed">32453280</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaire N., Deshmukh S., Agarwal E., Mahale N., Khaladkar S., Desai S., Kulkarni A. Pneumomediastinum: A marker of severity in COVID-19 disease. Heliyon. 2023;9:e12981. doi: 10.1016/j.heliyon.2023.e12981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e12981</ArticleId><ArticleId IdType="pmc">PMC9834123</ArticleId><ArticleId IdType="pubmed">36647393</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F., Yin G., Chen Y., Song J., Ye M., Liu J., Chen C., Song Y., Tang X., Zhang Y. Corticosteroid, oseltamivir and delayed admission are independent risk factors for prolonged viral shedding in patients with Coronavirus Disease 2019. Clin. Respir. J. 2020;14:1067–1075. doi: 10.1111/crj.13243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/crj.13243</ArticleId><ArticleId IdType="pmc">PMC7436608</ArticleId><ArticleId IdType="pubmed">32750201</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H., Han X., Jiang N., Cao Y., Alwalid O., Gu J., Fan Y., Zheng C. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study. Lancet Infect. Dis. 2020;20:425–434. doi: 10.1016/S1473-3099(20)30086-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30086-4</ArticleId><ArticleId IdType="pmc">PMC7159053</ArticleId><ArticleId IdType="pubmed">32105637</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso D., Zerunian M., Polici M., Pucciarelli F., Polidori T., Rucci C., Guido G., Bracci B., De Dominicis C., Laghi A. Chest CT Features of COVID-19 in Rome, Italy. Radiology. 2020;296:E79–E85. doi: 10.1148/radiol.2020201237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020201237</ArticleId><ArticleId IdType="pmc">PMC7194020</ArticleId><ArticleId IdType="pubmed">32243238</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamaskani N., Khandashpoor M., Livani S. Pneumothorax, Pneumomediastinum, and Subcutaneous Emphysema as Complications of COVID-19 Infection: A Case Series. Tanaffos. 2021;20:368–372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9577210</ArticleId><ArticleId IdType="pubmed">36267925</ArticleId></ArticleIdList></Reference><Reference><Citation>Eperjesiova B., Hart E., Shokr M., Sinha P., Ferguson G.T. Spontaneous Pneumomediastinum/Pneumothorax in Patients with COVID-19. Cureus. 2020;12:e8996. doi: 10.7759/cureus.8996.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.8996</ArticleId><ArticleId IdType="pmc">PMC7336633</ArticleId><ArticleId IdType="pubmed">32642391</ArticleId></ArticleIdList></Reference><Reference><Citation>Tacconi F., Rogliani P., Leonardis F., Sarmati L., Fabbi E., De Carolis G., La Rocca E., Vanni G., Ambrogi V. Incidence of pneumomediastinum in COVID-19: A single-center comparison between 1st and 2nd wave. Respir. Investig. 2021;59:661–665. doi: 10.1016/j.resinv.2021.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resinv.2021.04.010</ArticleId><ArticleId IdType="pmc">PMC8162722</ArticleId><ArticleId IdType="pubmed">34108126</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuinness G., Zhan C., Rosenberg N., Azour L., Wickstrom M., Mason D.M., Thomas K.M., Moore W.H. Increased Incidence of Barotrauma in Patients with COVID-19 on Invasive Mechanical Ventilation. Radiology. 2020;297:E252–E262. doi: 10.1148/radiol.2020202352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020202352</ArticleId><ArticleId IdType="pmc">PMC7336751</ArticleId><ArticleId IdType="pubmed">32614258</ArticleId></ArticleIdList></Reference><Reference><Citation>Anzueto A., Frutos–Vivar F., Esteban A., Alía I., Brochard L., Stewart T., Benito S., Tobin M.J., Elizalde J., Palizas F., et al. Incidence, risk factors and outcome of barotrauma in mechanically ventilated patients. Intensive Care Med. 2004;30:612–619. doi: 10.1007/s00134-004-2187-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-004-2187-7</ArticleId><ArticleId IdType="pubmed">14991090</ArticleId></ArticleIdList></Reference><Reference><Citation>Abenavoli L., Aquila I., Sacco M.A., Scarlata G.G.M., Procopio A.C., Boccuto L., Scarpellini E., Greco M., Foti D.P., Ricci P., et al. Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series. Diseases. 2023;11:141. doi: 10.3390/diseases11040141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diseases11040141</ArticleId><ArticleId IdType="pmc">PMC10594514</ArticleId><ArticleId IdType="pubmed">37873785</ArticleId></ArticleIdList></Reference><Reference><Citation>Negri S., Mazzuca E., Lococo F., Mondoni M., Covino M., Kuzmych K., Agati S., Amata M., Giuseppe A., Gabbrielli L., et al. Pneumomediastinum in COVID-19: Risk Factors and Outcomes from a Multicentre Case-control Study. Respir. Med. 2024;230:107684. doi: 10.1016/j.rmed.2024.107684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2024.107684</ArticleId><ArticleId IdType="pubmed">38823564</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua N.G., Loo L., Hee D.K.H., Lim T.P., Ng T.M., Hoo G.S.R., Soong J.L., Ong J.C.L., Tang S.S.L., Zhou Y.P., et al. Therapeutic drug monitoring of meropenem and piperacillin-tazobactam in the Singapore critically ill population—A prospective, multi-center, observational study (BLAST 1) J. Crit. Care. 2022;68:107–113. doi: 10.1016/j.jcrc.2021.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2021.12.013</ArticleId><ArticleId IdType="pubmed">34999376</ArticleId></ArticleIdList></Reference><Reference><Citation>Teo Y.X., Geetha H.S., Mishra A.K., Lal A. Pneumomediastinum in COVID-19: Incidence, Pathogenesis, and Management. Respiratory Care. Mediastinum. 2023;8:3. doi: 10.21037/med-23-39.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/med-23-39</ArticleId><ArticleId IdType="pmc">PMC10839521</ArticleId><ArticleId IdType="pubmed">38322185</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>